Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Establishment of digital cutoff values for intraepithelial lymphocytes in biopsies from colonic mucosa with lymphocytic colitis.

Fiehn AK, Clausen LN, Engel U, Munck LK, Kristensson M, Engel PJH.

Pathol Res Pract. 2019 Aug 8:152580. doi: 10.1016/j.prp.2019.152580. [Epub ahead of print]

PMID:
31522788
2.

Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.

de Boer AZ, van der Hulst HC, de Glas NA, Marang-van de Mheen PJ, Siesling S, de Munck L, de Ligt KM, Portielje JEA, Bastiaannet E, Liefers GJ.

Oncologist. 2019 Sep 12. pii: theoncologist.2019-0412. doi: 10.1634/theoncologist.2019-0412. [Epub ahead of print]

PMID:
31515242
3.

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.

de Boer AZ, Bastiaannet E, de Glas NA, Marang-van de Mheen PJ, Dekkers OM, Siesling S, de Munck L, de Ligt KM, Portielje JEA, Liefers GJ.

Breast Cancer Res Treat. 2019 Aug 26. doi: 10.1007/s10549-019-05412-8. [Epub ahead of print]

PMID:
31451977
4.

Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction.

Samiei S, van Kaathoven BN, Boersma L, Granzier RWY, Siesling S, Engelen SME, de Munck L, van Kuijk SMJ, van der Hulst RRJW, Lobbes MBI, Smidt ML, van Nijnatten TJA.

Ann Surg Oncol. 2019 Jul 29. doi: 10.1245/s10434-019-07643-x. [Epub ahead of print]

PMID:
31359276
5.

Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.

Voelkel V, Draeger T, Groothuis-Oudshoorn CGM, de Munck L, Hueting T, Gerken M, Klinkhammer-Schalke M, Lavric M, Siesling S.

J Cancer Res Clin Oncol. 2019 Jul;145(7):1823-1833. doi: 10.1007/s00432-019-02904-4. Epub 2019 Mar 29.

6.

Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy.

Samiei S, van Nijnatten TJA, de Munck L, Keymeulen KBMI, Simons JM, Kooreman LFS, Siesling S, Lobbes MBI, Smidt ML.

Ann Surg. 2018 Dec 13. doi: 10.1097/SLA.0000000000003126. [Epub ahead of print]

PMID:
30557203
7.

Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study.

van Maaren MC, de Munck L, Strobbe LJA, Sonke GS, Westenend PJ, Smidt ML, Poortmans PMP, Siesling S.

Int J Cancer. 2019 Jan 15;144(2):263-272. doi: 10.1002/ijc.31914. Epub 2018 Nov 28.

PMID:
30368776
8.

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.

Meurs CJC, van Rosmalen J, Menke-Pluijmers MBE, Ter Braak BPM, de Munck L, Siesling S, Westenend PJ.

Br J Cancer. 2018 Oct;119(9):1155-1162. doi: 10.1038/s41416-018-0276-6. Epub 2018 Oct 17.

PMID:
30327564
9.

Is revision of cutoff values needed when using CD3 immunohistochemical staining in histopathologic diagnosis of lymphocytic colitis?

Fiehn AK, Clausen LN, Engel U, Wildt S, Munck LK, Kristensson M, Engel PJH.

Hum Pathol. 2019 Feb;84:115-123. doi: 10.1016/j.humpath.2018.08.031. Epub 2018 Sep 18.

PMID:
30240770
10.

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.

Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A; BUG-1/LMC Study Group.

Gastroenterology. 2018 Dec;155(6):1795-1804.e3. doi: 10.1053/j.gastro.2018.08.042. Epub 2018 Sep 7.

11.

Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.

van Maaren MC, Lagendijk M, Tilanus-Linthorst MMA, de Munck L, Pijnappel RM, Schmidt MK, Wesseling J, Koppert LB, Siesling S.

Eur J Cancer. 2018 Sep;101:134-142. doi: 10.1016/j.ejca.2018.07.003. Epub 2018 Jul 28.

PMID:
30059817
12.

Microscopic colitis in Denmark and Sweden: incidence, putative risk factors, histological assessment and endoscopic activity.

Davidson S, Sjöberg K, Engel PJH, Lo Rinc E, Fiehn AK, Vigren L, Munck LK.

Scand J Gastroenterol. 2018 Jun - Jul;53(7):818-824. doi: 10.1080/00365521.2018.1476583. Epub 2018 May 31.

PMID:
29852792
13.

The subtypes of microscopic colitis from a pathologist's perspective: past, present and future.

Engel PJH, Fiehn AK, Munck LK, Kristensson M.

Ann Transl Med. 2018 Feb;6(3):69. doi: 10.21037/atm.2017.03.16.

14.

Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?

de Munck L, Fracheboud J, de Bock GH, den Heeten GJ, Siesling S, Broeders MJM.

Int J Cancer. 2018 Aug 15;143(4):842-850. doi: 10.1002/ijc.31388. Epub 2018 Apr 6.

15.

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.

Sankatsing VDV, Fracheboud J, de Munck L, Broeders MJM, van Ravesteyn NT, Heijnsdijk EAM, Verbeek ALM, Otten JDM, Pijnappel RM, Siesling S, de Koning HJ; National Evaluation Team for Breast cancer screening, NETB.

BMC Cancer. 2018 Mar 5;18(1):256. doi: 10.1186/s12885-018-4122-2.

16.

Risk of osteoporosis in microscopic colitis.

Wildt S, Munck LK, Becker S, Brockstedt H, Bonderup OK, Hitz MF.

Postgrad Med. 2018 Apr;130(3):348-354. doi: 10.1080/00325481.2018.1441579. Epub 2018 Feb 22.

PMID:
29460653
17.

A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial.

Bouman-Wammes EW, van den Berg HP, de Munck L, Beeker A, Smorenburg CH, Vervenne WL, Coenen JLLM, Verheul HMW, Gerritsen WR, Van den Eertwegh AJM.

Eur J Cancer. 2018 Feb;90:1-9. doi: 10.1016/j.ejca.2017.11.021. Epub 2017 Dec 18.

PMID:
29268139
18.

Parenteral therapy and complications in patients with intestinal failure in a regional unit.

Lorentsen R, Munck LK, Wildt S.

Scand J Gastroenterol. 2017 Dec;52(12):1326-1330. doi: 10.1080/00365521.2017.1380840. Epub 2017 Sep 22.

PMID:
28936879
19.

From metabolome to phenotype: GC-MS metabolomics of developing mutant barley seeds reveals effects of growth, temperature and genotype.

Khakimov B, Rasmussen MA, Kannangara RM, Jespersen BM, Munck L, Engelsen SB.

Sci Rep. 2017 Aug 15;7(1):8195. doi: 10.1038/s41598-017-08129-0.

20.

TNM classification and the need for revision of pN3a breast cancer.

van Nijnatten TJA, Moossdorff M, de Munck L, Goorts B, Vane MLG, Keymeulen KBMI, Beets-Tan RGH, Lobbes MBI, Smidt ML.

Eur J Cancer. 2017 Jul;79:23-30. doi: 10.1016/j.ejca.2017.04.002.

PMID:
28458119
21.

Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.

Borup C, Wildt S, Rumessen JJ, Bouchelouche PN, Graff J, Damgaard M, McQuitty C, Rainteau D, Munck LK.

Aliment Pharmacol Ther. 2017 Jun;45(11):1433-1442. doi: 10.1111/apt.14056. Epub 2017 Apr 5.

22.

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.

Elshof LE, Schaapveld M, Rutgers EJ, Schmidt MK, de Munck L, van Leeuwen FE, Wesseling J.

Breast Cancer Res. 2017 Mar 9;19(1):26. doi: 10.1186/s13058-017-0819-4.

23.

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.

van Nijnatten TJ, Simons JM, Moossdorff M, de Munck L, Lobbes MB, van der Pol CC, Koppert LB, Luiten EJ, Smidt ML.

Breast Cancer Res Treat. 2017 May;163(1):159-166. doi: 10.1007/s10549-017-4157-0. Epub 2017 Feb 17.

24.

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.

Goorts B, van Nijnatten TJ, de Munck L, Moossdorff M, Heuts EM, de Boer M, Lobbes MB, Smidt ML.

Breast Cancer Res Treat. 2017 May;163(1):83-91. doi: 10.1007/s10549-017-4155-2. Epub 2017 Feb 15.

25.

Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?

Habraken V, van Nijnatten TJ, de Munck L, Moossdorff M, Heuts EM, Lobbes MB, Smidt ML.

Breast Cancer Res Treat. 2017 Feb;161(3):483-489. doi: 10.1007/s10549-016-4071-x. Epub 2016 Dec 3.

26.

Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.

van Maaren MC, de Munck L, Jobsen JJ, Poortmans P, de Bock GH, Siesling S, Strobbe LJA.

Breast Cancer Res Treat. 2016 Dec;160(3):511-521. doi: 10.1007/s10549-016-4012-8. Epub 2016 Oct 11.

PMID:
27730424
27.

Catalytic Enantioselective Aza-Reformatsky Reaction with Cyclic Imines.

De Munck L, Vila C, Muñoz MC, Pedro JR.

Chemistry. 2016 Dec 5;22(49):17590-17594. doi: 10.1002/chem.201604606. Epub 2016 Oct 24.

PMID:
27775191
28.

Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers.

de Munck L, de Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, Siesling S.

Br J Cancer. 2016 Aug 23;115(5):517-24. doi: 10.1038/bjc.2016.226. Epub 2016 Aug 4.

29.

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, Poortmans P, Strobbe LJA, Siesling S.

Lancet Oncol. 2016 Aug;17(8):1158-1170. doi: 10.1016/S1470-2045(16)30067-5. Epub 2016 Jun 22.

PMID:
27344114
30.

Automated image analysis in the study of collagenous colitis.

Fiehn AM, Kristensson M, Engel U, Munck LK, Holck S, Engel PJ.

Clin Exp Gastroenterol. 2016 Apr 8;9:89-95. doi: 10.2147/CEG.S101219. eCollection 2016.

31.

CD3 immunohistochemical staining in diagnosis of lymphocytic colitis.

Fiehn AM, Engel U, Holck S, Munck LK, Engel PJ.

Hum Pathol. 2016 Feb;48:25-31. doi: 10.1016/j.humpath.2015.09.037. Epub 2015 Oct 29.

PMID:
26772395
32.

The Temporal Evolution of Histological Abnormalities in Microscopic Colitis.

Rasmussen J, Engel PJ, Wildt S, Fiehn AM, Munck LK.

J Crohns Colitis. 2016 Mar;10(3):262-8. doi: 10.1093/ecco-jcc/jjv200. Epub 2015 Oct 31.

33.

Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly.

van Rooijen JM, de Munck L, Teeuwen GM, de Graaf JC, Jansman FG, Boers JE, Siesling S.

Anticancer Drugs. 2016 Feb;27(2):127-32. doi: 10.1097/CAD.0000000000000310.

PMID:
26473525
34.

Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.

Borup C, Syversen C, Bouchelouche P, Damgaard M, Graff J, Rumessen JJ, Munck LK.

Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1399-402. doi: 10.1097/MEG.0000000000000476.

PMID:
26426834
35.

Combination therapy with bortezomib, continuous low-dose cyclophosphamide and dexamethasone followed by one year of maintenance treatment for relapsed multiple myeloma patients.

de Waal EG, de Munck L, Hoogendoorn M, Woolthuis G, van der Velden A, Tromp Y, Vellenga E, Hovenga S.

Br J Haematol. 2015 Dec;171(5):720-5. doi: 10.1111/bjh.13653. Epub 2015 Sep 11.

PMID:
26358087
36.

Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn's Disease.

Steenholdt C, Brynskov J, Thomsen OØ, Munck LK, Christensen LA, Pedersen G, Kjeldsen J, Ainsworth MA.

J Crohns Colitis. 2015 Nov;9(11):1032-42. doi: 10.1093/ecco-jcc/jjv139. Epub 2015 Aug 5.

PMID:
26245216
37.

Hormone receptors as a marker of poor survival in epithelial ovarian cancer.

van Kruchten M, van der Marel P, de Munck L, Hollema H, Arts H, Timmer-Bosscha H, de Vries E, Hospers G, Reyners A.

Gynecol Oncol. 2015 Sep;138(3):634-9. doi: 10.1016/j.ygyno.2015.06.032. Epub 2015 Jun 24.

PMID:
26115976
38.

Enantioselective alkynylation of benzo[e][1,2,3]-oxathiazine 2,2-dioxides catalysed by (R)-VAPOL-Zn complexes: synthesis of chiral propargylic cyclic sulfamidates.

De Munck L, Monleón A, Vila C, Muñoz MC, Pedro JR.

Org Biomol Chem. 2015 Jul 21;13(27):7393-6. doi: 10.1039/c5ob01012h.

PMID:
26081255
39.

Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.

van der Heiden-van der Loo M, de Munck L, Sonke GS, van Dalen T, van Diest PJ, van den Bongard HJ, Peeters PH, Rutgers EJ.

Eur J Cancer. 2015 May;51(8):915-21. doi: 10.1016/j.ejca.2015.03.014. Epub 2015 Apr 6.

PMID:
25857549
40.

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.

Steenholdt C, Brynskov J, Thomsen OØ, Munck LK, Fallingborg J, Christensen LA, Pedersen G, Kjeldsen J, Jacobsen BA, Oxholm AS, Kjellberg J, Bendtzen K, Ainsworth MA.

Dig Dis Sci. 2015 Sep;60(9):2762-70. doi: 10.1007/s10620-015-3581-4. Epub 2015 Feb 12.

PMID:
25673037
41.

Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease.

Steenholdt C, Bendtzen K, Brynskov J, Thomsen OØ, Munck LK, Christensen LA, Pedersen G, Kjeldsen J, Ainsworth MA.

J Crohns Colitis. 2015 Mar;9(3):238-45. doi: 10.1093/ecco-jcc/jjv004. Epub 2015 Jan 9.

PMID:
25576753
42.

[A fatal overdose of venlafaxine].

Pedersen JS, Munck LK.

Ugeskr Laeger. 2014 Feb 24;176(9A):V09130539. Danish.

PMID:
25350413
43.

[Microscopic colitis is a common cause of chronic diarrhoea].

Munck LK, Wildt S, Engell PJ, Bonderup OK.

Ugeskr Laeger. 2014 Feb 17;176(8A):V10130601. Review. Danish.

PMID:
25350302
44.

The use of shared medication record as part of medication reconciliation at hospital admission is feasible.

Munck LK, Hansen KR, Mølbak AG, Balle H, Kongsgren S.

Dan Med J. 2014 May;61(5):A4817.

PMID:
24814735
45.

Breast cancer screening halves the risk of breast cancer death: a case-referent study.

Paap E, Verbeek AL, Botterweck AA, van Doorne-Nagtegaal HJ, Imhof-Tas M, de Koning HJ, Otto SJ, de Munck L, van der Steen A, Holland R, den Heeten GJ, Broeders MJ.

Breast. 2014 Aug;23(4):439-44. doi: 10.1016/j.breast.2014.03.002. Epub 2014 Apr 6.

PMID:
24713277
46.

Quality improvement by implementing an integrated oncological care pathway for breast cancer patients.

van Hoeve J, de Munck L, Otter R, de Vries J, Siesling S.

Breast. 2014 Aug;23(4):364-70. doi: 10.1016/j.breast.2014.01.008. Epub 2014 Feb 25.

PMID:
24582455
47.

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.

van Rooijen JM, de Munck L, de Graaf JC, Siesling S, de Vries EG, Boers JE.

Eur J Cancer. 2014 Mar;50(5):885-91. doi: 10.1016/j.ejca.2014.01.010. Epub 2014 Jan 31.

PMID:
24491395
48.

Attending the breast screening programme after breast cancer treatment: a population-based study.

de Munck L, Kwast A, Reiding D, de Bock GH, Otter R, Willemse PH, Siesling S.

Cancer Epidemiol. 2013 Dec;37(6):968-72. doi: 10.1016/j.canep.2013.09.003. Epub 2013 Sep 26.

PMID:
24075800
49.

Observer variability in the histopathologic diagnosis of microscopic colitis and subgroups.

Fiehn AM, Bjørnbak C, Warnecke M, Engel PJ, Munck LK.

Hum Pathol. 2013 Nov;44(11):2461-6. doi: 10.1016/j.humpath.2013.06.004. Epub 2013 Sep 9.

PMID:
24029708
50.

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients.

Bantema-Joppe EJ, van den Heuvel ER, de Munck L, de Bock GH, Smit WG, Timmer PR, Dolsma WV, Jansen L, Schröder CP, Siesling S, Langendijk JA, Maduro JH.

Breast Cancer Res Treat. 2013 Aug;140(3):577-85. doi: 10.1007/s10549-013-2650-7. Epub 2013 Aug 3.

PMID:
23912958

Supplemental Content

Support Center